CLEC10A and neoplasm: Even though this finding was unique to the patient and could not be observed in 32 other gliomas, the method might be useful to identify the absence of HERV-K (HML-2) sequences normally located in tumor suppressor genes, such as BRCA2, XRCC1, and NBPFs, as a marker for oncogenesis (Figure 8) [251,252].